IMPROVEMENTS IN PATIENT-REPORTED OUTCOMES AMONG PATIENTS WITH RESOLUTION OF ENTHESITIS AND/OR DACTYLITIS: POST HOC ANALYSES FROM THE KEEPSAKE 1 AND 2 TRIALS OF RISANKIZUMAB IN PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS

被引：0
|
作者：
Kwatra, S. [1 ]
Khattri, S. [2 ]
Amin, A. [3 ]
Liu, R. [4 ]
Padilla, B. [4 ]
Soliman, A. M. [4 ]
Kaplan, B. [4 ]
Mcgonagle, D. [5 ,6 ]
机构：
[1] Johns Hopkins Univ, Dept Dermatol, Baltimore, MD USA
[2] Mt Sinai, Dept Dermatol, New York, NY USA
[3] Northwestern Med Dermatol, Dermatol, Chicago, IL USA
[4] AbbVie, Dept Immunol, N Chicago, IL USA
[5] Univ Washington, Div Rheumatol, Seattle, WA USA
[6] Univ Leeds, Leeds Teaching Hosp NHS Trust, Leeds, W Yorkshire, England
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2023年 / 82卷
关键词：
Spondyloarthritis; Enthesitis; Pain;
D O I：
10.1136/annrheumdis-2023-eular.2790
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
AB0957
引用
收藏
页码：1696 / 1697
页数：2
相关论文
共 50 条
  • [31] Improvements in Patient-Reported Outcomes Through Six Months of Guselkumab Treatment in Patients With Active Psoriatic Arthritis: Real-World Data From the CorEvitas Psoriatic Arthritis/Spondyloarthritis Registry
    Mease, Philip J.
    Ogdie, Alexis
    Tesser, John
    Shiff, Natalie J.
    Zhao, Ruizhi Sophia
    Chakravarty, Soumya D.
    Kelleman, Michael
    Dodge, Rhiannon
    McLean, Robert R.
    Broadwell, Aaron
    Kavanaugh, Arthur
    Merola, Joseph F.
    ACR OPEN RHEUMATOLOGY, 2024, 6 (05) : 304 - 311
  • [32] Impact of risankizumab on achieving minimal clinically important differences in patient-reported disease activity, fatigue, and pain among patients with active psoriatic arthritis: Analysis of 2 phase 3 clinical trials
    Kristensen, Lars Erik
    Soliman, Ahmed
    Papp, Kim
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2022, 87 (03) : AB68 - AB68
  • [33] The effect of secukinumab on patient-reported outcomes in patients with active psoriatic arthritis in a randomised phase 3 trial
    Strand, Vibeke
    Kaeley, Gurjit S.
    Bergman, Martin J.
    Gladman, Dafna D.
    Coates, Laura C.
    Sherif, Bintu
    Hur, Peter
    Parikh, Bhumik
    Gilloteau, Isabelle
    Mease, Philip J.
    LANCET RHEUMATOLOGY, 2022, 4 (03): : E208 - E219
  • [34] Effect of tofacitinib on patient-reported outcomes in patients with active psoriatic arthritis: Results from two phase 3 studies
    Strand, Vibeke
    de Vlam, Kurt
    Covarrubias-Cobos, Jose
    Mease, Philip
    Gladman, Dafna
    Hendrikx, Thijs
    Graham, Daniela
    Wu, Joseph
    Chen, Linda
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2017, 76 (06) : AB109 - AB109
  • [35] EFFECT OF TOFACITINIB ON PATIENT-REPORTED OUTCOMES IN PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS: RESULTS FROM TWO PHASE 3 STUDIES
    Strand, V.
    de Vlam, K.
    Covarrubias-Cobos, J. A.
    Mease, P. J.
    Gladman, D. D.
    Hendrikx, T.
    Kudlacz, E.
    Graham, D.
    Wu, J.
    Chen, L.
    ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 1335 - 1336
  • [36] THE IMPACT OF ADALIMUMAB VS PLACEBO ON PATIENT-REPORTED OUTCOMES AND UTILITY MEASURES AMONG PATIENTS WITH MODERATELY TO SEVERELY ACTIVE PSORIATIC ARTHRITIS
    Strand, V.
    Patel, P.
    Chen, N.
    Lesser, E.
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 1718 - 1719
  • [37] The Impact of Adalimumab vs Placebo on Patient-Reported Outcomes and Utility Measures Among Patients with Moderately to Severely Active Psoriatic Arthritis
    Strand, Vibeke
    Patel, Pankaj
    Chen, Naijun
    Lesser, Elizabeth M.
    ARTHRITIS & RHEUMATOLOGY, 2019, 71
  • [38] Association between low hemoglobin, clinical measures, and patient-reported outcomes in patients with rheumatoid arthritis: results from post hoc analyses of three phase III trials of sarilumab
    Andrea Rubbert-Roth
    Daniel E. Furst
    Stefano Fiore
    Amy Praestgaard
    Vivian Bykerk
    Clifton O. Bingham
    Christina Charles-Schoeman
    Gerd Burmester
    Arthritis Research & Therapy, 24
  • [39] Association between low hemoglobin, clinical measures, and patient-reported outcomes in patients with rheumatoid arthritis: results from post hoc analyses of three phase III trials of sarilumab
    Rubbert-Roth, Andrea
    Furst, Daniel E.
    Fiore, Stefano
    Praestgaard, Amy
    Bykerk, Vivian
    Bingham, Clifton O.
    Charles-Schoeman, Christina
    Burmester, Gerd
    ARTHRITIS RESEARCH & THERAPY, 2022, 24 (01)
  • [40] Relationships Between Minimal Disease Activity and Patient-Reported Outcomes in Patients with Psoriatic Arthritis: Post Hoc Analysis of Two Phase 3 Studies
    Helliwell, Philip
    Bushmakin, Andrew
    Gladman, Dafna
    FitzGerald, Oliver
    Fallon, Lara
    Cappelleri, Joseph
    Hsu, Ming-Ann
    Coates, Laura
    ARTHRITIS & RHEUMATOLOGY, 2019, 71
12345